Blog
RSS FeedPosted by Michael Wonder on 21 Jan 2024
Advanced melanoma treatment to be added to Pharmaceutical Benefits Scheme
21 January 2024 - Treatment for advanced melanoma is set to become cheaper under the Pharmaceutical Benefits Scheme in the ...
Posted by Michael Wonder on 18 Jan 2024
Updates to the HTA Policy and Methods Review Reference Committee (18 January 2024)
18 January 2024 - Communiques for three HTA Review Reference Committee meetings held in December 2023 are now available. ...
Posted by Michael Wonder on 17 Jan 2024
PBAC - 2023 in review
18 January 2024 - In contrast to New Zealand, 2023 saw many new medicines listed on the PBS. ...
Posted by Michael Wonder on 14 Jan 2024
DoH publishes revised agenda for March 2024 PBAC meeting (version 3)
5 January 2024 - The Department of Health has published a revised agenda (version 3) for the March 2024 PBAC ...
Posted by Michael Wonder on 14 Jan 2024
Public summary documents (first time decisions not to recommend and deferrals) – September 2023 PBAC meeting
12 January 2024 - The public summary documents (first time decisions not to recommend and deferrals) from the September 2023 PBAC ...
Posted by Michael Wonder on 04 Jan 2024
Updates to the HTA review research and analysis papers collection: draft HTA expert papers published
4 January 2024 - Two draft papers developed to support the deliberations of the HTA Review Reference Committee have been ...
Posted by Michael Wonder on 02 Jan 2024
Expanded PBS listings make vital treatments more affordable
2 January 2024 - From 1 January 2024, Australians with advanced ovarian cancer, CLL, SLL, cystic fibrosis and atypical haemolytic uraemic ...
Posted by Michael Wonder on 01 Jan 2024
Schedule of Pharmaceutical Benefits - 1 January 2024
1 January 2024 - The January 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 28 Dec 2023
Public Summary Documents – September 2023 PBAC meeting
22 December 2023 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the September 2023 PBAC ...
Posted by Michael Wonder on 24 Dec 2023
AstraZeneca cancer drug Calquence cost tumbles with PBS listing
23 December 2023 - An AstraZeneca drug’s listing on the PBS from January 1 will see bills fall massively for people ...
Posted by Michael Wonder on 22 Dec 2023
PBS Expenditure and Prescriptions Report 2022-23
22 December 2023 - The PBS Expenditure and Prescriptions Report 1 July 2022 to 30 June 2023 is now available. ...
Posted by Michael Wonder on 17 Dec 2023
Recommendations made by the PBAC (November 2023)
18 December 2023 - Recommendations made by the PBAC in November 2023 relating to the listing of medicines on the ...
Posted by Michael Wonder on 16 Dec 2023
Report on the collection of under co-payment data 2022-23
15 December 2023 - The report on the collection of under co-payment data 2022-23 is now available. ...
Posted by Michael Wonder on 11 Dec 2023
Cheaper medicines for breast cancer, small cell lung cancer, biliary tract cancer, juvenile idiopathic arthritis and Crohn's disease
11 December 2023 - From 1 December 2023, Australians with small cell lung cancer, biliary tract cancer, juvenile idiopathic arthritis and ...
Posted by Michael Wonder on 09 Dec 2023
Medicines lobby says the PBS has not kept up with advances — or approvals — in medicines
8 December 2023 - Little Jack Roche was five weeks old when diagnosed with cystic fibrosis. The medication that could help ...